Accueil>>Signaling Pathways>> Others>> Inhibitory Antibodies>>Ivuxolimab

Ivuxolimab

Catalog No.GC69303

Ivuxolimab est un anticorps monoclonal agoniste d'OX40 (également appelé CD134 ; TNFRSF4), OX40 étant un récepteur de co-stimulation exprimé sur les lymphocytes T CD4+ et CD8+ activés. Ivuxolimab possède une activité antitumorale et un potentiel d'activation immunitaire.

Products are for research use only. Not for human use. We do not sell to patients.

Ivuxolimab Chemical Structure

Cas No.: 2128729-41-7

Taille Prix Stock Qté
5mg
936,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Ivuxolimab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ivuxolimab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.